GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
S

SYN-Tech Chem & Pharm Co 1777.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

74.70

-1.58%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 1.30bn

FY2016FY2025

Net income

TWD 261.6m

FY2016FY2025

Free cash flow

TWD 501.2m

FY2016FY2025

Shareholders' equity

TWD 2.59bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 1.30bnTWD 1.26bnTWD 1.11bnTWD 986.3mTWD 893.2mTWD 983.8mTWD 946.4mTWD 784.8mTWD 695.0mTWD 766.8m
Gross profitTWD 450.4mTWD 486.9mTWD 402.5mTWD 361.0mTWD 284.0mTWD 364.7mTWD 298.8mTWD 244.7mTWD 194.3mTWD 295.2m
Research and developmentTWD 38.9mTWD 42.5mTWD 37.9mTWD 36.8mTWD 36.5mTWD 24.0mTWD 24.1mTWD 28.6mTWD 27.4mTWD 33.6m
Operating incomeTWD 319.9mTWD 351.0mTWD 281.9mTWD 238.2mTWD 168.6mTWD 262.4mTWD 200.6mTWD 149.5mTWD 101.5mTWD 188.2m
Net incomeTWD 261.6mTWD 393.3mTWD 251.0mTWD 295.3mTWD 177.2mTWD 186.7mTWD 159.5mTWD 154.0mTWD 59.8mTWD 158.5m
Diluted earnings per share5.868.815.636.564.426.215.313.451.343.55

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 2.96bnTWD 2.85bnTWD 2.90bnTWD 2.78bnTWD 2.90bnTWD 1.78bnTWD 1.86bnTWD 1.82bnTWD 1.56bnTWD 1.29bn
Cash and short-term investments——TWD 666.9mTWD 964.1mTWD 1.49bnTWD 619.1mTWD 639.3mTWD 653.9mTWD 459.6mTWD 356.3m
Total liabilitiesTWD 369.6mTWD 291.6mTWD 583.5mTWD 580.1mTWD 911.7mTWD 541.5mTWD 700.9mTWD 725.9mTWD 559.6mTWD 259.9m
Debt——TWD 402.8mTWD 428.0mTWD 765.1mTWD 374.0mTWD 541.6mTWD 551.5mTWD 424.5mTWD 64.1m
Shareholders' equityTWD 2.59bnTWD 2.56bnTWD 2.32bnTWD 2.20bnTWD 1.98bnTWD 1.24bnTWD 1.16bnTWD 1.10bnTWD 996.2mTWD 1.03bn
Shares outstanding45m45m45m45m40m30m30m45m45m45m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsTWD 559.5mTWD 622.6mTWD 262.3mTWD 438.8mTWD 157.0mTWD 319.2mTWD 228.1mTWD 188.5mTWD 42.9mTWD 235.3m
Capital spending−TWD 58.3m−TWD 213.8m−TWD 437.3m−TWD 477.4m−TWD 127.2m−TWD 64.6m−TWD 63.2m−TWD 77.3m−TWD 207.4m−TWD 185.7m
Free cash flowTWD 501.2mTWD 408.9m−TWD 175.1m−TWD 38.6mTWD 29.8mTWD 254.6mTWD 164.9mTWD 111.2m−TWD 164.5mTWD 49.5m
Dividends paid−TWD 236.3m−TWD 156.1m−TWD 133.8m−TWD 86.1m−TWD 120.2m−TWD 105.2m−TWD 99.2m−TWD 52.6m−TWD 105.2m−TWD 105.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 336.4mTWD 275.6mTWD 322.9mTWD 336.7mTWD 324.8mTWD 315.8mTWD 314.3mTWD 330.6m
Gross profitTWD 141.2mTWD 111.2mTWD 131.7mTWD 110.0mTWD 92.2mTWD 116.4mTWD 130.0mTWD 108.4m
Operating incomeTWD 105.3mTWD 77.7mTWD 95.6mTWD 79.6mTWD 61.3mTWD 83.3mTWD 93.6mTWD 74.6m
Net incomeTWD 90.6mTWD 71.7mTWD 91.9mTWD 77.4mTWD 16.6mTWD 75.8mTWD 91.3mTWD 116.0m
Diluted earnings per share2.031.612.061.730.371.702.052.60
Cash from operationsTWD 38.0mTWD 44.0mTWD 256.0m—TWD 114.0mTWD 115.0mTWD 151.0mTWD 327.0m
Capital spending−TWD 13.0m−TWD 14.0m−TWD 21.0m—−TWD 13.0m−TWD 15.0m−TWD 136.0m−TWD 17.0m
Free cash flowTWD 25.0mTWD 30.0mTWD 235.0m—TWD 101.0mTWD 100.0mTWD 15.0mTWD 310.0m
Total assetsTWD 3.16bnTWD 3.02bnTWD 2.96bnTWD 2.70bnTWD 2.95bnTWD 2.89bnTWD 2.85bnTWD 2.70bn
Cash and short-term investments———TWD 684.4m————
Debt———TWD 55.2m————
Shareholders' equityTWD 2.58bnTWD 2.48bnTWD 2.59bnTWD 2.49bnTWD 2.42bnTWD 2.40bnTWD 2.56bnTWD 2.46bn

Financial ratios

Data as of 23 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Gross margin34.6%38.7%36.1%36.6%31.8%37.1%——
Operating margin25.8%39.0%25.3%24.2%18.9%26.7%——
Net margin20.1%31.3%22.5%29.9%19.8%19.0%——
Return on equity10.1%15.4%10.8%13.4%8.9%15.1%——
Return on assets8.8%13.8%8.7%10.6%6.1%10.5%——
Free cash flow yield—24.9%20.8%27.0%9.4%17.0%12.9%—
Revenue growth3.4%12.8%13.0%10.4%-9.2%3.9%——
Earnings growth-33.5%56.7%-15.0%66.7%-5.1%17.1%——
Current ratio5.03x6.08x2.80x3.17x2.54x2.20x——
Debt to equity——0.15x0.17x0.36x0.26x0.42x0.50x
Equity ratio87.5%89.8%79.9%79.1%68.5%69.6%——
Interest coverage333.92x229.04x49.12x40.24x49.72x74.88x——
R&D as a share of sales3.0%3.4%3.4%3.7%4.1%2.4%——
Buybacks as a share of market value—-0.1%1.0%-12.4%-33.3%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue9.6%5.7%6.6%
Operating income10.3%4.0%6.6%
Net income-4.0%7.0%5.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.6%36.5%35.9%34.9%
Operating margin26.2%25.6%24.8%23.3%
Net margin25.6%25.8%23.9%21.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings12.610.715.112.814.812.415.622.753.827.4
Price to sales2.53.33.43.82.92.42.64.54.65.7

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 21 Jul 2025.

FY2025FY2024FY2023FY2022
Paid in the year5.303.503.001.931
  • 1.05-for-1 split · 3 Aug 2012
  • 110-for-100 split · 23 Jul 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.